Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-11-22

Clinical Trial Update: The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry [NA]

View source ↗

Summary

A completed clinical trial comparing the anti-inflammatory effects of extrafine HFA-beclometasone versus HFA-fluticasone in asthma using inflammometry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Extrafine HFA-Beclometasone (beclomethasone dipropionate)
  • HFA-Fluticasone (fluticasone propionate)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Asthma | NA | Status: COMPLETED